Decentralized Clinical Trial –
1,400+ Participants

The Challenge

I was challenged with finding participants for a decentralized clinical study to evaluate an at-home colon cancer screening test. The client asked me to find a minimum of 1,000 participants for a multi-step trial had various inclusions and requirements.

  • Must be at least 45 years old

  • No colonoscopy in the last ten years

  • Average risk of colon cancer

Requirements

  • Collect then return an at-home stool sample via a provided kit

  • Schedule, attend and self-finance an in-office colonoscopy procedure with a gastroenterologist of their choice

  • Assist with the medical records collection process

Inclusion & Exclusion

Pre-study Pilot: I developed and conducted a smaller scale pilot to refine processes and help determine which approach was best suited

Project Strategy: I designed an end-to-end project for decentralized study recruitment using the LEAN process: Locate, Educate, Activate, Navigate

The Results

This successful project resulted in 1,402 trial completions, 40% more than requested. My client was also able to secure “Breakthrough Device” designation from the FDA and funding for an additional large pivotal study. Additional benefits included:

  • 66% timeline reduction

  • 1,400+ diverse participants set

  • 1st participant final analysis in under 6 months

  • Dataset finalization and analysis completed in 5 days

The Strategy

With so many moving parts, it was essential that all participant activity be trackable in real time, then documented and time stamped.

The Process:

Client Satisfaction:

“We are so grateful that we chose this agency to assist with our clinical trials. They’ve dramatically improved our ability to locate and manage a high volume of qualified patients in a short window of time. This agency provided a streamlined, end-to-end solution to efficiently recruit patients in a highly efficient and cost-effective manner. These contributions will help us to deliver innovative technology to patients and physicians on an expedited pathway.”

Andrew Barnell | CEO

Previous
Previous

Moderna RSV Vaccine Recruitment (Strategy)

Next
Next

Medical Patient Recruitment (Marketing Strategy)